Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics

MLA

Nicolette, Stogios, et al. “Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics.” Journal of Clinical Psychopharmacology, vol. 43, Nov. 2022, pp. 60–63. EBSCOhost, https://doi.org/10.1097/jcp.0000000000001626.

APA

Nicolette, S., Margaret K, H., Yona, L., Pushpal, D., & Sri Mahavir, A. (2022). Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics. Journal of Clinical Psychopharmacology, 43, 60–63. https://doi.org/10.1097/jcp.0000000000001626

Chicago

Nicolette, Stogios, Hahn Margaret K, Lunsky Yona, Desarkar Pushpal, and Agarwal Sri Mahavir. 2022. “Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics.” Journal of Clinical Psychopharmacology 43 (November): 60–63. doi:10.1097/jcp.0000000000001626.